William A. Curran
Lawyers
Filters
GSK strategic collaboration with CAMP4 Therapeutics
We advised GSK on the transaction
HNI senior secured notes exchange offer
We advised HNI on the exchange offer
Emera C$600 million at-the-market offering
We advised Emera on the offering
Semrush Holdings $1.9 billion sale to Adobe
We are advising Semrush on the transaction
AkzoNobel $25 billion merger of equals with Axalta Coating Systems
We are advising AkzoNobel on the transaction
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
GSK exclusive license agreement with Empirico
We advised GSK on the transaction
Evernorth de-SPAC transaction and $1.1 billion committed equity financing
Evernorth is expected to be the largest public XRP treasury company
Upgrade Series G equity financing
We advised Upgrade in connection with the transaction
Emera $750 million fixed-to-fixed reset rate junior subordinated notes offering
We advised Emera on its offering